Trial intelligence / Profile preview

Esflurbiprofen plaster vs flurbiprofen tablet in knee osteoarthritis

jRCTs031180228Completed

Sponsor
Taisho Pharmaceutical
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of esflurbiprofen in knee osteoarthritis (OA) (2 arms), sponsored by Taisho Pharmaceutical. Primary endpoint: Agent concentration in tissue. Started Mar 2019; status: completed.

02

Drugs

esflurbiprofen
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on jRCTs031180228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call